Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%)
< Home < Back

Natco Pharma reports 28% rise in Q2 consolidated net profit

Date: 19-11-2013

Natco Pharma has reported results for the second quarter ended September 30, 2013.

The company has reported 20.19% rise in its net profit at Rs 28.69 crore for the quarter as compared to Rs 23.87 crore for the same quarter in the previous year. However, total income from operation of the company has decreased by 1.28% at Rs 150.06 crore for quarter under review as compared to Rs 152.02 crore for the quarter ended September 30, 2012.

On the consolidated basis, the group has registered a growth of 28.25% in net profit after taxes and minority interest of Rs 26.92 crore as compared to Rs 20.99 crore in the same quarter previous year. However, total income from operation of the group has decreased by 0.61% to Rs 179.22 crore for quarter under review as against Rs 180.32 crore in corresponding quarter previous year.